Citation:Hubble DJ, Johnson V, Ramdave S, Hicks RJ 2008

From Clinical Guidelines Wiki


Hubble DJ, Johnson V, Ramdave S, Hicks RJ. Safety of therapeutic Lu-177 octreotate (LuTate) administration in patients previously treated with high-dose In-111 octreotide (HD-Oc) for neuroendocrine tumour (NET). Internal Medicine Journal 2008 [cited 2014 Jun 12];38(Suppl 3):A50.

Critical appraisals

Compare quality appraisals for each clinical question

Cited by

  1. NETs guidelines/Radionuclide Therapy